review of glp 1 Multifaceted Roles GLP-1 and Its Analogs: A on Molecular Mechanisms with a Cardiotherapeutic Perspective GLP-1 Agonists For Obesity In

According to the 2024 World Obesity Report, the global prevalence of obesity is steadily increasing, with projections indicating that by 2035, over half of the world's population will be classified as overweight [1]

Across the HF spectrum, their effects may differ according to phenotype, with potentially greater utility in patients with obesity or HFpEF, whereas their role in established HFrEF remains uncertain and should be individualized pending dedicated outcome trials [22]

Now, the medical community is buzzing about the next evolutionary leap: Retatrutide

Between being overweight and having insulin resistance, inflammation has rampaged my body for years